Table 1.

Characteristics of 7 patients with unresectable liver metastases treated with percutaneous hepatic perfusion

PT	Sexe/age	Type of cancer	Time between first diagnosis and PHP (months)	Time between diagnosis liver metastases and PHP (months)	No. PHP’s	Best response	Time to progr. (months)	Location of progression	Status	Follow-up after first perfusion (months)
1	M, 57	UM	105	34	2	PR	28	Liver	Alive	28a
2	F, 62	UM	36	6	1	PR	9	Liver	Dead	11
3	M, 42	UM	36	3	1	PR	11	Bone, liver	Alive	26
4	M, 58	CRC	34	34	1	SD	1	Lymph node, LTR	Dead	7
5	M, 46	CRC	28	27	2	PR	5	Lung	Alive	27
6	F, 43	UM	40	16	2	PR	14	Liver	Alive	25b
7	M, 64	CRC	30	30	2	SD	5	Lung	Alive	24

PT patient, PHP percutaneous hepatic perfusion, UM uveal melanoma, CRC colorectal cancer, LTR local tumour recurrence at colonic anastomosis

^a2nd perfusion was followed by radiofrequency ablation (RFA) of 6 small residual tumours

^b2nd perfusion was followed by RFA of 3 small residual tumours. Because of hepatic progression, another 2 perfusions were performed